Table 2. Toxoplasmosis seroprevalence by demographic factor and stratified by self-reported nationality, as recorded by national perinatal survey, France, 2016 (n = 13,173).
Demographics | French women | North African women | Sub-Saharan African women | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Seroprevalence | aPR | 95% CI | Seroprevalence | aPR | 95% CI | Seroprevalence | aPR | 95% CI | ||||
n/N | % | n/N | % | n/N | % | |||||||
Age (years) | ||||||||||||
< 20 | 31/158 | 19.6 | 0.59 | 0.41‒0.83 | NA | NA | NA | NA | 16/22 | 72.7 | 1.19 | 0.89–1.60 |
20–24 | 205/1,249 | 16.4 | 0.50 | 0.44–0.57 | 17/57 | 29.8 | 0.72 | 0.46–1.13 | 40/83 | 48.2 | 0.93 | 0.69–1.24 |
25–29 | 794/3,341 | 23.8 | 0.73 | 0.67–0.78 | 55/180 | 30.6 | 0.78 | 0.59–1.04 | 68/156 | 43.6 | 0.93 | 0.72–1.20 |
30–35 | 1,203/3,606 | 33.4 | Ref | NA | 71/179 | 39.7 | Ref | NA | 70/160 | 43.8 | Ref | NA |
35–39 | 708/1,732 | 40.9 | 1.20 | 1.11–1.29 | 62/132 | 47.0 | 1.16 | 0.90–1.50 | 52/88 | 59.1 | 1.43 | 1.12–1.84 |
≥ 40 | 210/395 | 53.2 | 1.54 | 1.39–1.70 | 22/35 | 62.9 | 1.50 | 1.10–2.05 | 13/22 | 59.1 | 1.27 | 0.87–1.86 |
Professional status of household | ||||||||||||
Without a profession | 62/238 | 26.1 | 1.03 | 0.82–1.28 | 10/27 | 37.0 | 1.09 | 0.63–1.89 | 22/37 | 59.5 | 1.21 | 0.84–1.75 |
Manual | 171/695 | 24.6 | 0.98 | 0.86–1.13 | 55/135 | 40.7 | 1.25 | 0.90–1.75 | 29/69 | 42.0 | 0.84 | 0.58–1.21 |
Employee | 788/2,942 | 26.8 | 0.99 | 0.91–1.07 | 68/158 | 43.0 | 1.24 | 0.91–1.70 | 78/192 | 40.6 | 0.89 | 0.66–1.20 |
Intermediate professional | 1,012/3,410 | 29.7 | Ref | NA | 37/106 | 34.9 | Ref | NA | 31/68 | 45.6 | Ref | NA |
Higher professional | 754/2,052 | 36.7 | 1.12 | 1.04–1.21 | 18/66 | 27.3 | 0.89 | 0.56–1.41 | 13/33 | 39.4 | 0.92 | 0.56–1.50 |
Farmer/ commerce | 334/1,047 | 31.9 | 1.08 | 0.98–1.19 | 3277 | 41.6 | 1.29 | 0.89–1.87 | 58/88 | 65.9 | 1.05 | 0.77–1.43 |
ZEAT | ||||||||||||
East | 149/798 | 18.7 | 0.67 | 0.57–0.79 | 13/28 | 46.4 | 1.07 | 0.67–1.73 | 9/14 | 64.3 | 1.76 | 1.05–2.94 |
Centre-east | 327/1,334 | 24.5 | 0.84 | 0.75–0.95 | 24/62 | 38.7 | 0.84 | 0.54–1.31 | 12/24 | 50.0 | 1.43 | 0.82–2.48 |
West | 401/1,453 | 27.6 | 0.97 | 0.87–1.09 | 12/24 | 50.0 | 1.14 | 0.68–1.89 | 13/28 | 46.4 | 1.37 | 0.80–2.33 |
North | 213/766 | 27.8 | 1.05 | 0.92–1.21 | 3/36 | 8.3 | 0.07 | 0.01–0.51 | 2/8 | 25.0 | 0.83 | 0.24–2.90 |
Paris basin | 471/1,730 | 27.2 | Ref | NA | 23/56 | 41.1 | Ref | NA | 18/51 | 35.3 | Ref | NA |
Mediterranean | 339/1,007 | 33.7 | 1.16 | 1.03–1.30 | 30/86 | 34.9 | 0.79 | 0.52–1.20 | 7/14 | 50.0 | 1.31 | 0.66–2.61 |
South-west | 343/968 | 35.4 | 1.21 | 1.08–1.36 | 24/46 | 52.2 | 1.14 | 0.76–1.71 | 12/24 | 50.0 | 1.42 | 0.81–2.48 |
Paris | 706/1,940 | 36.4 | 1.19 | 1.08–1.31 | 96/238 | 40.3 | 0.96 | 0.69–1.34 | 88/238 | 37.0 | 1.01 | 0.67–1.50 |
Overseas departmentsa | 191/440 | 43.4 | 1.59 | 1.39–1.82 | NA | NA | NA | NA | 97/128 | 75.8 | 2.11 | 1.43–3.12 |
aPR: adjusted prevalence ratio ; CI: confidence interval; Ref: reference category used in the analysis; ZEAT: zones d’étude et d’aménagement du territoire (study and regional planning zone, equivalent to Nomenclature of territorial units for statistics level 1 (NUTS 1)).
Values in bold represent a significant difference p < 0.05.
Only variables which were statistically significant on MVA for any of the strata are shown.
a Guadeloupe, French Guyana, La Réunion, Martinique and Mayotte combined.